Monika Haemmerle

The paper analyzes codon usage patterns in pancreatic cancer to show how oncogenic gene expression is systematically optimized through GC content, preferred codons, and cost-effective amino acids.

This study identifies FOXM1 as a gene regulated by platelets that controls anoikis resistance in pancreatic cancer cells, suggesting it as a potential therapeutic target.